Status:
TERMINATED
Effect of an Anti-Oxidant Treatment on Resistin Serum Levels.A Randomized Study
Lead Sponsor:
University of Turin, Italy
Conditions:
Metabolic Diseases
Oxidative Stress
Eligibility:
All Genders
20-50 years
Phase:
PHASE3
Brief Summary
The aim of the present study was to evaluate whether an in vivo treatment with an antioxidant vitamin (vitamin C) might substantially affect serum levels of resistin, a recently described adipokine, w...
Detailed Description
INTRODUCTION Background Resistin, a recently described adipokine, belonging to the cysteine-rich secretory protein family, was originally described as an adipocyte-derived polypeptide, that provides...
Eligibility Criteria
Inclusion
- age 20-50 years
- absence of known hyperglycemia, hypertension, cardiovascular disease, impaired renal function, liver disease, or any other systemic conditions no use of any drug, estrogen included
- not being on a particular diet and/or vitamin or other nutrient supplementation
Exclusion
- actual pregnancy
- known hyperglycemia, hypertension, cardiovascular disease, impaired renal function, liver disease, or any other systemic conditions
- use of any drug, estrogen included
- being on a particular diet, vitamin or other nutrient supplementation
- history of renal calculi.
Key Trial Info
Start Date :
June 1 2005
Trial Type :
INTERVENTIONAL
End Date :
November 1 2005
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00387114
Start Date
June 1 2005
End Date
November 1 2005
Last Update
October 12 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Internal Medicine, University of Turin
Turin, Italy, 10126